Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Innate Pharma
  6. Company
    IPH   FR0010331421

INNATE PHARMA

(IPH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Innate Pharma
Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The Company develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. The Company works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The Company operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.

Number of employees : 237 people.
Sales per Business
20192020Delta
Therapeutic Antibodies85.81124.4%70.45124% -17.9%
EUR in Million
Sales per region
20192020Delta
France85.81124.4%70.45124% -17.9%
EUR in Million
Managers
Name Title Age Since
Mondher Mahjoubi, Dr. Chairman-Executive Board & Chief Executive Officer 62 2016
Frederic Lombard Chief Financial Officer - 2021
Eric Vivier, Dr. Chief Scientific Officer & Senior Vice President 57 2018
Odile Belzunce Senior VP-Compliance, IT & Operations 40 2019
Joyson Joseph Karakunnel, Dr. Chief Medical Officer & Executive Vice President 50 2020
Patrick J. Langlois, Dr. Independent Member-Supervisory Board 75 2010
Irina Staatz-Granzer, Dr. Vice Chairman-Supervisory Board 61 2012
Véronique Chabernaud, Dr. Independent Member-Supervisory Board 59 2015
Jean-Yves Blay, Dr. Independent Member-Supervisory Board 58 2018
Pascale Boissel Independent Member-Supervisory Board 54 2020
Members of the board
Name Title Age Since
Hervé Eloi Dominique Brailly, Dr. Chairman-Supervisory Board 59 1999
Patrick J. Langlois, Dr. Independent Member-Supervisory Board 75 2010
Irina Staatz-Granzer, Dr. Vice Chairman-Supervisory Board 61 2012
Gilles Brisson Member-Supervisory Board 68 2016
Véronique Chabernaud, Dr. Independent Member-Supervisory Board 59 2015
Maïlys Ferrère Member-Supervisory Board 57 2017
Jean-Yves Blay, Dr. Independent Member-Supervisory Board 58 2018
Marcus Schindler Member-Supervisory Board 54 2018
Pascale Boissel Independent Member-Supervisory Board 54 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 78,986,490 59,437,323 75.2% 18,575 0.0% 75.2%
Stock B 0 7,581 0 0.0% 0 0.0%
Stock C 0 6,881 0 0.0% 0 0.0%
Shareholders
NameEquities%
Novo Nordisk A/S 9,817,546 12.4%
Bpifrance Participations SA /PRIVATE EQUITY/ 8,952,467 11.3%
AstraZeneca PLC 7,485,500 9.48%
Hervé Eloi Dominique Brailly 885,884 1.12%
BlackRock Fund Advisors 365,055 0.46%
Baillie Gifford & Co. 355,227 0.45%
Sycomore Asset Management SA 349,573 0.44%
Saint Olive Gestion SNC 345,000 0.44%
Mondher Mahjoubi 342,511 0.43%
Wellington Management Co. LLP 328,000 0.42%
Holdings
NameEquities%Valuation
INNATE PHARMA (IPH) 18,575 0.024% 59,564 USD
Markets and indexes
- PEA / SRD eligible : YES / YES
- Compartiment B
- Next 150 / CAC All Shares, CAC All-Tradable, CAC Mid Small, CAC PME, CAC Small, EnterNext© PEA-PME 150, Next Biotech, PEA, PEA-PME, Tech 40
Stock Exchange Codes
- Bloomberg Code :  IPH:FP
- Reuters Code :  IPH.PA
- Datastream Code :  
Company contact information
Innate Pharma
117 Avenue de Luminy
BP 30191
FR-13009 Marseille

Phone : +33 (0)4 30 30 30 30
Fax : +33 (0)4 30 30 30 00
web site : http://www.innate-pharma.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Innate Pharma
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
INNATE PHARMA-18.31%265
MODERNA, INC.238.47%141 980
LONZA GROUP AG23.98%57 809
IQVIA HOLDINGS INC.38.25%47 462
CELLTRION, INC.-29.39%30 059
SEAGEN INC.-12.42%27 907
CUREVAC N.V.-39.24%21 497
ALNYLAM PHARMACEUTICALS, INC.37.68%21 034
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.62.86%20 449
PHARMARON BEIJING CO., LTD.64.43%20 226
ICON PUBLIC LIMITED COMPANY24.77%19 385
BIO-TECHNE CORPORATION51.86%18 755
HANGZHOU TIGERMED CONSULTING CO., LTD-2.48%18 276
INCYTE CORPORATION-11.07%17 011
PPD, INC.34.78%16 203
NOVAVAX, INC.60.82%13 285
QIAGEN N.V.-0.11%12 062
PRA HEALTH SCIENCES, INC.0.00%10 965
INTELLIA THERAPEUTICS, INC.160.75%10 305
BACHEM HOLDING AG51.71%9 267
SYNEOS HEALTH, INC.31.62%9 265